Terms Defined Elsewhere Clause Samples

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Acquisition 7.3(d) Agreement Preamble Apogent Preamble Apogent Balance Sheet 3.1(d)(iv) Apogent Benefit Plans 3.1(i)(i) Apogent Bylaws 3.1(a)(ii) Apogent Charter 3.1(a)(ii) Apogent Common Stock 2.1 Apogent Disclosure Schedule 3.1 Apogent Leased Real Property 3.1(r) Apogent Material Contract 3.1(q)(i) Apogent Option 2.1(d) Apogent Organizational Documents 3.1(a)(ii) Apogent Owned Real Property 3.1(r) Apogent Permits 3.1(g)(i) Apogent Preferred Stock 3.1(b)(i) Apogent Purchase Plan 2.1(d) Apogent Restricted Stock Unit 5.11(a)(ii) Apogent Rights 3.1(b)(i) Apogent Rights Agreement 3.1(b)(i) Apogent SEC Documents 3.1(d)(i) Apogent Shareholder Approval 3.1(c)(iii) Apogent Shareholders’ Meeting 5.1(b) Apogent Significant Subsidiaries 3.1(a)(iii) Apogent Stock Plans 3.1(b)(i) Apogent Subsidiary Organizational Documents 3.1(a)(ii) Apogent Termination Fee 7.3(a) Apogent Third Party Bidder 7.3(a)(i) Applicable Laws 3.1(g)(ii) Approval 3.1(i)(ii) Articles of Merger 1.3 Benefit Continuation Period 5.11(c) Benefit Plans 3.1(i)(i) CDA 4.2(c)(i) Certificates 2.2(b) Change of Recommendation 4.2(d)(ii) Closing 1.2 Closing Date 1.2 Code Recitals DFI 1.3 Effect 8.3(k) Effective Time 1.3 ERISA 3.1(i)(i) ERISA Affiliate 3.1(i)(v) Exchange Act 3.1(c)(v)(B)(2) Exchange Agent 2.2(a) (a) Exchange Ratio 2.1(a) FDA 3.1(g)(i)

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Amendment to the Company Management Agreement Recitals Articles of Merger 2.2(b) Book-Entry Shares 3.3(b)(i) Cancelled Shares 3.1(b)(v) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble Company Additional Dividend Amount 6.19(a) Company Affiliate 9.10(a) Company Board Recitals Company Board Recommendation Recitals Company Change of Recommendation 6.3(b) Company Common Stock 3.1(b)(i) Company Contracts 3.2(b) Company DER Consideration 3.2(b) Company Director Designee 2.6 Company Disclosure Letter Article IV Company Dividend Equivalent Right 3.2(b) Company Material Adverse Effect 4.1(a) Company Permits 4.9 Company Plans 4.10(a) Company SEC Documents 4.5(a) Company Series A Preferred Stock 3.1(b)(iii) Company Series B Preferred Stock 3.1(b)(iii) Company Series C Preferred Stock 3.1(b)(iii) Company Special Committee Recitals Company Stockholders Recitals Company Stockholders Meeting 4.4 Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) Delaware LLC Act 2.1 Delaware Secretary of State 2.2(b) e-mail 9.3 Effective Time 2.2(b) End Date 8.1(b)(ii) Exchange Agent 3.3(a) Exchange Fund 3.3(a) Forfeited Phantom Shares 3.2(a) GAAP 4.5(b) Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) Leverage Covenants 6.1(a)(xiv) Maryland Courts 9.7(b) Maryland Department 2.2(b) Material Company Insurance Policies 4.17 Material Parent Insurance Policies 5.17 Merger Recitals Merger Filings 2.2(b) Merger Sub Preamble Merger Sub Sole Member Recitals MGCL 2.1 Operating Partnership 2.1 Parent Preamble Parent Additional Dividend Amount 6.19(b) Parent Affiliate 9.10(b) Parent Board Recitals Parent Board Recommendation 5.3(a) Parent Change of Recommendation 6.4(b) Parent Common Stock Issuance Recitals Parent Contracts 5.16(b) Parent Disclosure Letter Article V Parent Equity Plan 5.2(a) Parent Management Agreement Amendment Recitals Parent Manager Recitals Parent Material Adverse Effect 5.1(a) Parent Permits 5.9 Parent Plans 5.10(a) Parent SEC Documents 5.5(a) Parent Stock Issuance Recitals Parent Stockholders Recitals .pdf 9.5 Per Share Common Merger Consideration 3.1(b)(i) Per Share Preferred Merger Consideration 3.1(b)(iii) Per Share Preferred Series B Merger Consideration 3.1(b)(iii) Per Share Preferred...

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: 401(k) Termination Date Section 7.7(c) Acceptance Time Section 1.1(f) Adjusted Option Section 3.4(b) Adjusted RSU Section 3.4(d) Agreement Preamble Arrangements Section 7.14 Book-Entry Shares Section 3.2(b) Cancelled Shares Section 3.1(b) Certificates Section 3.2(b) Change of Recommendation Section 6.3(a) Closing Section 2.2 Closing Date Section 2.2 COBRA Section 4.10(d) Company Preamble Company Benefit Plans Section 4.10(a) Company Board of Directors Recitals Company Board Recommendation Recitals Company Capitalization Date Section 4.2(a) Company Common Stock Recitals Company Compensation Committee Section 7.14 Company Disclosure Letter Article IV Company Equity Schedule Section 4.2(b) Company Permits Section 4.9(b) Company Preferred Stock Section 4.2(a) Company SEC Documents Section 4.5(a) Company Shares Recitals Company Stockholders Recitals Convertible Senior Notes Section 7.15 DGCL Recitals Dissenting Shares Section 3.3(a) DOJ Section 7.2(b) Enforceability Limitations Section 4.3(c) Exchange Agent Section 3.2(a) Exchange Fund Section 3.2(a) Fractional Share Consideration Section 3.1(a) FTC Section 7.2(b) GAAP Section 4.5(b) Indemnified Parties Section 7.4(a) Indenture Section 7.15 Intervening Event Section 6.3(d) Material Contract Section 4.17(a) Minimum Condition Section 1.1(a)(i)

Terms Defined Elsewhere. In addition to the terms defined in Section 1.1, each of the following terms is defined in the Section of the Agreement set forth opposite such term below: Accounting Rules 5.6(b) ADSP 8.7(g) Allocation Schedule 8.7(g) Articles of Merger 2.2 Audited Buyer Financials 7.5(a) Audited Company Financials 5.6(a) Auditor 3.3(d)(i) Bank 5.1(a) Bank Merger 2.7 Bank Merger Agreement 2.7 Bankruptcy and Equity Exceptions 5.2 Basket 10.6(a)(i) BOLI 2.8(a)(ii)(C) Branch Leases 5.12(a)(i) Buyer Preamble Buyer Appraisal Delivery Date 3.4(a) Buyer Covered Losses 10.6(a)(i) Buyer Disclosure Schedule Preamble to Article 7 Buyer Indemnitee 10.1 Buyer Losses 10.1 Buyer Plans 8.6(b) Cap 10.6(a)(iii) Certificate 2.6(a) Claim Notice 10.3 Closed Branches 8.17 Closing 4.1 Closing Date 4.1 Closing Payment 3.1(a) Common Interest Information 8.22(c) Company Preamble Company Appraisal Delivery Date 3.4(c) Company Disclosure Schedule Preamble to Article 5 Company Financials 5.6(a) Company Plans 5.18(a) Company Stock Recitals Damages 10.1 Derivative Transactions 5.13 Disclosure Schedule 8.11 Dispute Notice 3.3(b) Disputed Matters 3.3(b) Effective Time 2.2 Environmental Laws 5.17 Environmental Survey 8.21(a) ESOP 5.18(e) Estimated Effective Time Balance Sheet 3.2 FBCA Recitals FHLBA 5.1 Final Losses 10.4(e) Final Net Book Value 3.3(e) First Negotiation Period 3.4(b) Fiserv Contract 2.8(a)(ii)(H) Fraud 10.6(a) FRB 1.1(d) FTMC 5.1(a) FTST 5.1(a) Incumbent Counsel 8.14(a) Indemnified Party 10.3 Indemnifying Party 10.3 Interim Company Financials 5.6(a) IRS 5.18(c) Lien 5.3 Losses 10.6(b) Material Contracts 5.12(b) Material Defect 8.21(d) Material Defect Notice 8.21(c) Merger Recitals Merger Consideration 3.1(a) Monthly Financials 8.19 Negative True-Up Amount 3.3(e)(ii) Net Book Value 2.8(b) Non-Continuing Employee 8.6(a) Non-Performing 2.10(b) OCC 1.1(d) Order 5.8 Other Transferred Assets 2.9 Outside Closing Date 11.1(b)(ii) Owned Branch Property 5.16 Parent Preamble Parent Covered Losses 10.6(a)(ii) Parent Disclosure Schedule Preamble to Article 6 Parent Indemnitee 10.2 Parent Losses 10.2 Parties Preamble Permits 5.9 Permitted Real Estate Liens and Exceptions 5.16 Plaintiff Litigation 8.22(a) Policies 5.18 Pool 5.11(g) Positive True-Up Amount 3.3(e)(i) Property Examination 8.21(a) Property Review Appraisal Factors 8.21(c) Property Review Period 8.21(a) Put Date 8.16(c) Put Notice 8.16(c) Put Period 8.16(a) Qualified MAI Appraiser 3.4(a) Regulatory Approval 9.1(c) Representatives 8.3(a) Repur...

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: "Acquisition Agreement" Section 6.3(d) "Additional Shortfall" Section 3.2(b)(iii) "Adverse Recommendation Change" Section 6.3(d) "Agreement" Preamble "Alternate Financing" Section 7.10(c) "Articles of Merger" Section 2.3 "Book-Entry Share" Section 3.1(b) "Cash Consideration" Section 3.1(a)(ii)(A) "Cash Election" Section 3.1(a)(ii)(A) "Cash Election Number" Section 3.2(b)(ii) "Cash Election Shares" Section 3.1(a)(ii)(A) "Certificate" Section 3.1(b) "Closing" Section 2.2 "Closing Date" Section 2.2 "Commitment Letter" Section 5.28(a) "Company" Preamble "Company Advisor Related Agreement" Section 4.23 "Company Agreements" Section 4.13(a) "Company Board Recommendation" Recitals "Company Disclosure Letter" Article IV "Company Financial Advisor" Section 4.20 "Company Financial Statements" Section 4.6 "Company Leases" Section 4.18(e) "Company Material Contract" Section 4.13(b) "Company Pending Acquisitions" Section 6.1(a)(vi) "Company Permits" Section 4.17(b) "Company Permitted Liens" Section 4.18(b) "Company Preferred Stock" Section 4.2(a) "Company Property(ies)" Section 4.18(a) "Company SEC Documents" Section 4.6 "Company Subsidiary Partnership" Section 4.12(g) "Company Tax Protection Agreements" Section 4.12(g) "Company Tax Representation Letter" Section 6.1(b) "Company Third Party" Section 4.18(h) "Company Title Insurance Policy(ies)" Section 4.18(j) "Company Voting Debt" Section 4.2(a) "Competing Proposal" Section 6.3(g) "Covered Persons" Section 7.5(a) "D&O Insurance" Section 7.5(d) "Effective Time" Section 2.3 "Election" Section 3.3(a) "Election Deadline" Section 3.3(d) "Exchange Agent" Section 3.3(d) "Exchange Agent Agreement" Section 3.3(d) "Exchange Fund" Section 3.4 "Financing" Section 5.28(a) "Form of Election" Section 3.3(b) "Holder" Section 3.3 "Indemnification Agreements" Section 7.5(a) "Interim Period" Section 6.1(a) "Legal Proceeding" Section 4.10 "Mailing Date" Section 3.3(c) "Master Leases" Section 4.18(e) "Maximum Cash Conversion Number" Section 3.2(a)(i) "Merger" Recitals "Merger Consideration" Section 3.1(a)(ii) "Merger Sub" Preamble "MGCL" Recitals "Minimum Cash Conversion Number" Section 3.2(a)(ii) "Minimum Cash Conversion Number Shortfall" Section 3.2(b)(iii)

Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble

Terms Defined Elsewhere. The following terms are defined herein in the sections identified below: